These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

603 related items for PubMed ID: 19454359

  • 1. Squamous cell carcinoma of the urinary bladder: a clinicopathologic and immunohistochemical study of 16 cases.
    Guo CC, Gomez E, Tamboli P, Bondaruk JE, Kamat A, Bassett R, Dinney CP, Czerniak BA.
    Hum Pathol; 2009 Oct; 40(10):1448-52. PubMed ID: 19454359
    [Abstract] [Full Text] [Related]

  • 2. Squamous cell carcinoma of the bladder: a clinicopathologic analysis of 45 cases.
    Lagwinski N, Thomas A, Stephenson AJ, Campbell S, Hoschar AP, El-Gabry E, Dreicer R, Hansel DE.
    Am J Surg Pathol; 2007 Dec; 31(12):1777-87. PubMed ID: 18043032
    [Abstract] [Full Text] [Related]

  • 3. Noninvasive squamous lesions in the urinary bladder: a clinicopathologic analysis of 29 cases.
    Guo CC, Fine SW, Epstein JI.
    Am J Surg Pathol; 2006 Jul; 30(7):883-91. PubMed ID: 16819332
    [Abstract] [Full Text] [Related]

  • 4. Prognostic value of apoptotic markers in squamous cell carcinoma of the urinary bladder.
    Youssef R, Kapur P, Shariat SF, Arendt T, Kabbani W, Mosbah A, Abol-Enein H, Ghoneim M, Lotan Y.
    BJU Int; 2012 Oct; 110(7):961-6. PubMed ID: 22372762
    [Abstract] [Full Text] [Related]

  • 5. P53 expression in small cell carcinoma of the urinary bladder: biological and prognostic implications.
    Wang X, Jones TD, Maclennan GT, Yang XJ, Lopez-Beltran A, Eble JN, Koch MO, Lin H, Baldridge LA, Tretiakova M, Cheng L.
    Anticancer Res; 2005 Oct; 25(3B):2001-4. PubMed ID: 16158936
    [Abstract] [Full Text] [Related]

  • 6. Plasmacytoid transitional cell carcinoma of urinary bladder: a clinicopathologic study of 9 cases.
    Ro JY, Shen SS, Lee HI, Hong EK, Lee YH, Cho NH, Jung SJ, Choi YJ, Ayala AG.
    Am J Surg Pathol; 2008 May; 32(5):752-7. PubMed ID: 18379419
    [Abstract] [Full Text] [Related]

  • 7. Clinicopathologic features and utility of immunohistochemical markers in signet-ring cell adenocarcinoma of the bladder.
    Thomas AA, Stephenson AJ, Campbell SC, Jones JS, Hansel DE.
    Hum Pathol; 2009 Jan; 40(1):108-16. PubMed ID: 18789486
    [Abstract] [Full Text] [Related]

  • 8. Nested variant of urothelial carcinoma: a clinicopathologic and immunohistochemical study of 30 pure and mixed cases.
    Wasco MJ, Daignault S, Bradley D, Shah RB.
    Hum Pathol; 2010 Feb; 41(2):163-71. PubMed ID: 19800100
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Expression of cell cycle-related molecular markers in patients treated with radical cystectomy for squamous cell carcinoma of the bladder.
    Youssef RF, Shariat SF, Kapur P, Kabbani W, Ghoneim T, King E, Cockburn A, Mosbah A, Abol-Enein H, Ghoneim M, Lotan Y.
    Hum Pathol; 2011 Mar; 42(3):347-55. PubMed ID: 21111452
    [Abstract] [Full Text] [Related]

  • 11. Laparoscopic radical cystectomy and extracorporeal urinary diversion: a single center experience of 48 cases with three years of follow-up.
    Hemal AK, Kolla SB, Wadhwa P, Dogra PN, Gupta NP.
    Urology; 2008 Jan; 71(1):41-6. PubMed ID: 18242362
    [Abstract] [Full Text] [Related]

  • 12. [New markers for pharmacological targeting in bladder cancer with lymph node metastasis].
    Herrmann E, Eltze E, Köpke T, Bolenz C, Bierer S, Neumann J, Hertle L, Wülfing C.
    Aktuelle Urol; 2007 Sep; 38(5):392-7. PubMed ID: 17907066
    [Abstract] [Full Text] [Related]

  • 13. Small cell carcinoma of the urinary bladder: a clinicopathologic analysis of 64 patients.
    Cheng L, Pan CX, Yang XJ, Lopez-Beltran A, MacLennan GT, Lin H, Kuzel TM, Papavero V, Tretiakova M, Nigro K, Koch MO, Eble JN.
    Cancer; 2004 Sep 01; 101(5):957-62. PubMed ID: 15329903
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Rhabdomyosarcoma of the urinary bladder in adults: predilection for alveolar morphology with anaplasia and significant morphologic overlap with small cell carcinoma.
    Paner GP, McKenney JK, Epstein JI, Amin MB.
    Am J Surg Pathol; 2008 Jul 01; 32(7):1022-8. PubMed ID: 18469707
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Pleomorphic giant cell carcinoma of the urinary bladder.
    Lopez-Beltran A, Blanca A, Montironi R, Cheng L, Regueiro JC.
    Hum Pathol; 2009 Oct 01; 40(10):1461-6. PubMed ID: 19467692
    [Abstract] [Full Text] [Related]

  • 18. Epidermal growth factor receptor protein expression and gene amplification in small cell carcinoma of the urinary bladder.
    Wang X, Zhang S, MacLennan GT, Eble JN, Lopez-Beltran A, Yang XJ, Pan CX, Zhou H, Montironi R, Cheng L.
    Clin Cancer Res; 2007 Feb 01; 13(3):953-7. PubMed ID: 17289890
    [Abstract] [Full Text] [Related]

  • 19. Outcomes of patients with clinical T1 grade 3 urothelial cell bladder carcinoma treated with radical cystectomy.
    Gupta A, Lotan Y, Bastian PJ, Palapattu GS, Karakiewicz PI, Raj GV, Schoenberg MP, Lerner SP, Sagalowsky AI, Shariat SF, Bladder Cancer Research Consortium.
    Urology; 2008 Feb 01; 71(2):302-7. PubMed ID: 18308108
    [Abstract] [Full Text] [Related]

  • 20. Heparin-binding epidermal growth factor-like growth factor isoforms and epidermal growth factor receptor/ErbB1 expression in bladder cancer and their relation to clinical outcome.
    Kramer C, Klasmeyer K, Bojar H, Schulz WA, Ackermann R, Grimm MO.
    Cancer; 2007 May 15; 109(10):2016-24. PubMed ID: 17394193
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.